On Monday, Oppenheimer reaffirmed its Perform rating for Cellectar Biosciences (NASDAQ:CLRB) shares, a micro-cap biotech currently ...

Investing.com – U.S. stocks were mixed after the close on Wednesday, as gains in the Industrials, Telecoms and Oil & Gas sectors... ByInvesting.com • Nov 23, 2016 Cellectar Bio tabs INC ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

At close: April 17 at 4:00:01 PM EDT ...

Caribou Biosciences, Inc. (NASDAQ:CRBU – Get Free Report) has been assigned a consensus recommendation of “Buy” from the five analysts that are covering the firm, MarketBeat reports.

NASDAQ:TYRA opened at $8.61 on Thursday. The company’s fifty day moving average price is $10.45 and its 200-day moving average price is $14.92. Tyra Biosciences has a 1-year low of $6.42 and a 1 ...

In this article, we are going to take a look at where TuHURA Biosciences, Inc. (NASDAQ:HURA) stands against other best rising penny stocks to buy according to analysts. The start of 2025 was ...

In this article, we are going to take a look at where TuHURA Biosciences, Inc. (NASDAQ:HURA) stands against other best rising penny stocks to buy according to analysts. The start of 2025 was ...

For more information, visit AccordBioPharma.com. About Coherus BioSciences Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company focused on the research, development and ...